Discover

CURX
Curanex Pharmaceuticals Inc
5.31
3 x 4.64
22 x 4.64
bid
ask
+
0.55
11.55%
13 @ 06:28 PM
5.43 +0.12 (2.26%)
Ytd-19.79%
1y-64.07%
4.61
day range
5.31
3.66
52 week range
16.00
Open4.61Prev Close4.76Low4.61High5.31Mkt Cap8.33M
Vol17.09KAvg Vol19.85KEPS-7.80P/EN/AForward P/EN/A
Beta-2.88Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg4.53200-d Avg6.371yr Est0.00
Income Statement
Operating Expenses3.33M
Research and Development Expense2.59M
Selling, General and Administrative Expense731.84K
Operating Income-3.33M
Net Income-3.29M
Net Income Common Stock-3.29M
Net Income Common Stock (USD)-3.29M
Consolidated Income-3.29M
Earnings per Basic Share-2.40
Earnings per Basic Share (USD)-2.40
Earnings per Diluted Share-2.40
Earning Before Interest & Taxes (EBIT)-3.29M
Earning Before Interest & Taxes (USD)-3.29M
Weighted Average Shares1.42M
Weighted Average Shares Diluted1.42M
Balance Sheet
Cash and Equivalents2.94M
Cash and Equivalents (USD)2.94M
Current Assets4.79M
Property, Plant & Equipment Net280.94K
Total Assets5.07M
Debt Current94.41K
Total Debt276.36K
Current Liabilities104.31K
Debt Non-Current181.95K
Total Liabilities286.25K
Accumulated Retained Earnings (Deficit)-11.29M
Shareholders Equity4.79M
Shareholders Equity (USD)4.79M
Assets Non-Current280.94K
Total Debt (USD)276.36K
Liabilities Non-Current181.95K
Trade and Non-Trade Payables154.00
Cash Flow
Depreciation, Amortization & Accretion36.64K
Net Cash Flow / Change in Cash & Cash Equivalents-1.08M
Net Cash Flow from Operations-1.08M